KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

ClearPoint Neuro (CLPT) Operating Expenses (2018 - 2026)

ClearPoint Neuro's Operating Expenses history spans 13 years, with the latest figure at $8.7 million for Q4 2025.

  • On a quarterly basis, Operating Expenses rose 31.64% to $8.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $30.4 million, a 24.68% increase, with the full-year FY2025 number at $30.4 million, up 24.68% from a year prior.
  • Operating Expenses hit $8.7 million in Q4 2025 for ClearPoint Neuro, up from $7.0 million in the prior quarter.
  • Over the last five years, Operating Expenses for CLPT hit a ceiling of $8.7 million in Q4 2025 and a floor of $3.2 million in Q1 2021.
  • Historically, Operating Expenses has averaged $5.8 million across 5 years, with a median of $5.4 million in 2023.
  • Biggest five-year swings in Operating Expenses: soared 110.31% in 2021 and later decreased 13.34% in 2024.
  • Tracing CLPT's Operating Expenses over 5 years: stood at $5.0 million in 2021, then rose by 5.85% to $5.3 million in 2022, then increased by 1.3% to $5.4 million in 2023, then increased by 22.73% to $6.6 million in 2024, then surged by 31.64% to $8.7 million in 2025.
  • Business Quant data shows Operating Expenses for CLPT at $8.7 million in Q4 2025, $7.0 million in Q3 2025, and $7.2 million in Q2 2025.